Repros Therapeutics (RPRX) Reports Q2 Loss of $0.18/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Repros Therapeutics Inc.® Reports Second Quarter 2016 Financial Results
August 9, 2016 9:15 AM EDTTHE WOODLANDS, Texas, Aug. 09, 2016 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq: RPRX) today announced financial results for the second quarter ended June 30, 2016.
Financial Results
Net loss for the three month period ended June 30, 2016, was ($4.3) million or ($0.18) per share as compared to a net loss of ($7.8) million or ($0.32) per share for the same period in 2015. The net loss for the six month period ended June 30, 2016, was ($9.1) million or ($0.38) per share as compared to a net loss of ($16.3) million or ($0.67) per... More
